---
$id: https://graph.org.ai/products/commodity/51152018
$type: Product
source: UNSPSC
code: "51152018"
title: "Butamisole"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Butamisole

**UNSPSC Code**: 51152018
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antihelminthic agent with the molecular formula C15H19N3OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XVB7982801, chemically known as propanamide, 2-methyl-n-(3-(2,3,5,6-tetrahydroimidazo(2,1-b)thiazol-6-yl)phenyl)-, (-)- but generally known as butamisole, which bears US NIH Compound Identifier 166572. Butamisole most often comes in base and hydrochloride forms. European Medicines Agency schedules Butamisole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06001MIG. The term BUTAMISOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). BUTAMISOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butamisole under HS 29349990 and SITC 51579. As of Q4 2014, BUTAMISOLE remains the US FDA Preferred Term for this commodity. Butamisole bears US NLM identifiers UMLS ID C0054237 and NCI Concept Code C79921. SMILES: S1C2=NC(CN2CC1)C1CC(NC(=O)C(C)C)CCC1.

